HPV Vaccine Information for Clinicians – Fact Sheet
Human papillomavirus (HPV) is the most common sexually transmitted infection and is associated with many types of cancers that disproportionately impact Hispanics. An HPV vaccine is available for individuals ages 9—45 that can prevent up to 90% of HPV-a
[16]Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec. 2014 Oct 24;89(43):465-91. English, French. PMID: 2534186960. [17]Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human papillomavirus prophylactic vaccines. Vaccine. 2012 Nov 2...
16. Human papillomavirus vaccines: WHO position paper, October 2014. Wkly Epidemiol Rec. 2014 Oct 24;89(43):465-91. English, French. PMID: 2534186960. 17. Schiller JT, Castellsagué X, Garland SM. A review of clinical trials of human...
PDS0101 is a type of vaccine that is intended to help the immune system respond to human papillomavirus (HPV16)-infected cervical tumor cells. PDS0101 contains two active components: the first is called R-DOTAP (Versamune) and is included in the vaccine to boost the immune system's response...
The new nine-valent vaccine against human papillomavirus (HPV) includes the four HPV genotypes (6, 11, 16, and 18) that are targeted by the older quadrivalent HPV vaccine, plus five additional oncogenic types (31, 33, 45, 52, and 58) remain significantly associated with high grade lesions...
Human Papilloma Virus ( HPV ) VaccineFactsheet, Cancer Information
Low values in Denmark and Spain are probably due to the specific items’ formulation: * In the Danish study, the wording of the item was: “Our son has already received the vaccine.” ** In the Spanish study, the wording of the item was: “I will have her vaccinated in a few weeks...